1. Zhao, Dongdong, Qiang, Lihua, Lei, Zehui, Liu, Cui Hua, Wang, Jing. 2024. TRIM27 elicits protective immunity against tuberculosis by activating TFEB-mediated autophagy flux. In Autophagy, 20, 1483-1504. doi:10.1080/15548627.2024.2321831. https://pubmed.ncbi.nlm.nih.gov/38390831/
2. Sakamoto, Toshiya, Kuboki, Satoshi, Furukawa, Katsunori, Yoshizumi, Arihito, Ohtsuka, Masayuki. 2022. TRIM27-USP7 complex promotes tumour progression via STAT3 activation in human hepatocellular carcinoma. In Liver international : official journal of the International Association for the Study of the Liver, 43, 194-207. doi:10.1111/liv.15346. https://pubmed.ncbi.nlm.nih.gov/35753056/
3. Wang, Tongjie, Xia, Chengxiang, Dong, Yong, Wang, Jinyong, Du, Juan. 2018. Trim27 confers myeloid hematopoiesis competitiveness by up-regulating myeloid master genes. In Journal of leukocyte biology, 104, 799-809. doi:10.1002/JLB.1A1217-480R. https://pubmed.ncbi.nlm.nih.gov/29897614/
4. Miao, Xiao, Xiang, Yanwei, Mao, Weiwei, Li, Qi, Fan, Bin. 2019. TRIM27 promotes IL-6-induced proliferation and inflammation factor production by activating STAT3 signaling in HaCaT cells. In American journal of physiology. Cell physiology, 318, C272-C281. doi:10.1152/ajpcell.00314.2019. https://pubmed.ncbi.nlm.nih.gov/31747314/
5. Zhang, Hao, Zheng, Yujia, Wang, Zhen, Li, Chunxiang, He, Jie. 2024. KLF12 interacts with TRIM27 to affect cisplatin resistance and cancer metastasis in esophageal squamous cell carcinoma by regulating L1CAM expression. In Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 76, 101096. doi:10.1016/j.drup.2024.101096. https://pubmed.ncbi.nlm.nih.gov/38924996/
6. Maat, Henny, Atsma, Tjerk Jan, Hogeling, Shanna M, van den Boom, Vincent, Schuringa, Jan Jacob. 2021. The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia. In iScience, 24, 102435. doi:10.1016/j.isci.2021.102435. https://pubmed.ncbi.nlm.nih.gov/34113809/
智鼠故事 
